Human medicines European public assessment report (EPAR): Symkevi, tezacaftor,ivacaftor, Cystic Fibrosis, Date of authorisation: 31/10/2018, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR): Symkevi, tezacaftor,ivacaftor, Cystic Fibrosis, Date of authorisation: 31/10/2018, Revision: 12, Status: Authorised